ARCHIVES

Natural Substance Blocks Androgen Activity In Vitro

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

HHS Appoints 13 To Genetics Committee

January 17, 2003

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

Compendia Publishers Must Tell CMS How They Manage Conflicts Of Interest

November 13, 2009

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

Shubik Subcommittee Criticizes New Study Section, Asks NCI To Hire More Epidemiologists

December 5, 1975

Without Advance Directives, Families Prolong Treatment

April 27, 2001